OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 18:36:07 02/07/2024 BST | ||
| 15.46 EUR | -0.51% |
|
| Current month | -0.83% | ||
| 1 month | +4.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 02/07/24 | 15.46 | -0.51% |
| 01/07/24 | 15.54 | -0.83% |
| 28/06/24 | 15.67 | -0.38% |
| 27/06/24 | 15.73 | -0.82% |
| 26/06/24 | 15.86 | -3.23% |
Real-time BOERSE MUENCHEN
Last update July 02, 2024 at 06:36 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TT9DKK |
| ISIN | DE000TT9DKK8 |
| Date issued | 14/10/2021 |
| Strike | 144.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.12 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.17 € |
|---|---|
| Lowest since issue | 5.94 € |
| Spread | 0.02 € |
| Spread % | 0.13% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
311
USD
Average target price
316.4
USD
Spread / Average Target
+1.75%
- Stock Market
- Certificates
- Certificat
